Tokio Marine Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Tokio Marine Asset Management's ALNY Position: Q2 2026 in Review
Tokio Marine Asset Management increased its Alnylam Pharmaceuticals (ALNY) stake by 0.68% in Q2 2026, buying an estimated $10.9K and bringing the position to 5,316 shares worth $1.6M. The position accounts for 0.05% of the portfolio, ranked #289.
Tokio Marine Asset Management first reported a position in ALNY in Q2 2021 and has held it in 17 quarters since. The position peaked at $2.03M in Q3 2025. 785 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.
- Tokio Marine Asset Management held 5,316 shares of Alnylam Pharmaceuticals worth $1.6M as of Q2 2026.
- Tokio Marine Asset Management bought 36 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $10.9K.
- Alnylam Pharmaceuticals made up 0.05% of Tokio Marine Asset Management's portfolio in Q2 2026, its #289 holding.
- Tokio Marine Asset Management first reported a position in Alnylam Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
- Tokio Marine Asset Management's Alnylam Pharmaceuticals position peaked at $2.03M in Q3 2025.
- 785 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.
Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.